Repression of GRIM19 expression potentiates cisplatin chemoresistance in advanced bladder cancer cells via disrupting ubiquitination-mediated Bcl-xL degradation. [electronic resource]
Producer: 20190729Description: 593-605 p. digitalISSN:- 1432-0843
- Animals
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Apoptosis Regulatory Proteins -- metabolism
- Cell Line, Tumor
- Cisplatin -- pharmacology
- Down-Regulation -- drug effects
- Drug Resistance, Neoplasm -- drug effects
- Gene Expression Profiling
- Humans
- Mice
- NADH, NADPH Oxidoreductases -- genetics
- Neoplasm Recurrence, Local
- Neoplasm Staging
- Protein Subunits
- Signal Transduction -- drug effects
- Ubiquitination -- drug effects
- Urinary Bladder Neoplasms -- drug therapy
- Xenograft Model Antitumor Assays
- bcl-X Protein -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.